Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Language Development Disorders | 7 | 2022 | 17 | 4.100 |
Why?
|
| Child | 30 | 2025 | 657 | 3.450 |
Why?
|
| Humans | 51 | 2025 | 5476 | 3.060 |
Why?
|
| Language Development | 7 | 2025 | 37 | 3.040 |
Why?
|
| Juvenile Delinquency | 4 | 2025 | 10 | 2.920 |
Why?
|
| Dyslexia | 5 | 2024 | 49 | 2.840 |
Why?
|
| Child Development | 5 | 2024 | 35 | 2.660 |
Why?
|
| Adolescent | 23 | 2025 | 806 | 2.550 |
Why?
|
| Mothers | 4 | 2025 | 54 | 2.310 |
Why?
|
| Male | 30 | 2025 | 2765 | 2.310 |
Why?
|
| Brain | 8 | 2024 | 286 | 2.270 |
Why?
|
| Violence | 3 | 2025 | 10 | 2.240 |
Why?
|
| Autism Spectrum Disorder | 3 | 2022 | 11 | 2.140 |
Why?
|
| DNA Methylation | 5 | 2021 | 30 | 2.130 |
Why?
|
| Female | 28 | 2025 | 2811 | 2.060 |
Why?
|
| Child, Preschool | 15 | 2025 | 187 | 1.970 |
Why?
|
| Epigenesis, Genetic | 4 | 2024 | 31 | 1.950 |
Why?
|
| HIV Infections | 4 | 2022 | 115 | 1.920 |
Why?
|
| Anger | 3 | 2025 | 9 | 1.780 |
Why?
|
| Reaction Time | 3 | 2024 | 60 | 1.670 |
Why?
|
| Cognition | 7 | 2024 | 174 | 1.660 |
Why?
|
| Evoked Potentials | 5 | 2025 | 29 | 1.560 |
Why?
|
| Mother-Child Relations | 3 | 2025 | 24 | 1.370 |
Why?
|
| Child, Orphaned | 2 | 2020 | 8 | 1.360 |
Why?
|
| Electroencephalography | 5 | 2024 | 134 | 1.350 |
Why?
|
| Criminals | 2 | 2023 | 8 | 1.350 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 12 | 1.350 |
Why?
|
| Infant | 8 | 2025 | 87 | 1.300 |
Why?
|
| Reading | 6 | 2024 | 77 | 1.300 |
Why?
|
| Emotions | 2 | 2021 | 83 | 1.280 |
Why?
|
| Institutionalization | 4 | 2025 | 11 | 1.220 |
Why?
|
| Young Adult | 10 | 2025 | 850 | 1.150 |
Why?
|
| Child, Institutionalized | 4 | 2025 | 10 | 1.150 |
Why?
|
| Recidivism | 3 | 2023 | 7 | 1.130 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2020 | 52 | 1.110 |
Why?
|
| Cerebral Cortex | 3 | 2020 | 53 | 0.960 |
Why?
|
| Russia | 6 | 2021 | 13 | 0.960 |
Why?
|
| Adult | 9 | 2025 | 1683 | 0.930 |
Why?
|
| Mouth | 1 | 2024 | 2 | 0.910 |
Why?
|
| Virtual Reality | 1 | 2024 | 5 | 0.900 |
Why?
|
| Task Performance and Analysis | 1 | 2024 | 23 | 0.890 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 18 | 0.880 |
Why?
|
| Microbiota | 1 | 2024 | 18 | 0.880 |
Why?
|
| Psycholinguistics | 3 | 2020 | 11 | 0.870 |
Why?
|
| Child of Impaired Parents | 2 | 2020 | 4 | 0.860 |
Why?
|
| Haplotypes | 3 | 2020 | 12 | 0.860 |
Why?
|
| Social Support | 2 | 2020 | 31 | 0.840 |
Why?
|
| Machine Learning | 1 | 2024 | 39 | 0.830 |
Why?
|
| Psychological Tests | 1 | 2023 | 9 | 0.800 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 14 | 0.800 |
Why?
|
| Language Tests | 2 | 2020 | 15 | 0.790 |
Why?
|
| Carrier Proteins | 2 | 2020 | 25 | 0.790 |
Why?
|
| Deafness | 1 | 2022 | 8 | 0.790 |
Why?
|
| Parenting | 2 | 2021 | 48 | 0.750 |
Why?
|
| Academic Performance | 1 | 2022 | 20 | 0.750 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2020 | 18 | 0.740 |
Why?
|
| Knowledge | 1 | 2021 | 3 | 0.740 |
Why?
|
| Aptitude | 1 | 2021 | 9 | 0.730 |
Why?
|
| Down Syndrome | 1 | 2021 | 16 | 0.720 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 20 | 0.710 |
Why?
|
| Facial Expression | 1 | 2021 | 12 | 0.710 |
Why?
|
| Nerve Tissue Proteins | 1 | 2021 | 35 | 0.700 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 52 | 0.700 |
Why?
|
| White Matter | 1 | 2021 | 24 | 0.700 |
Why?
|
| Multilingualism | 1 | 2021 | 24 | 0.700 |
Why?
|
| Language | 5 | 2024 | 55 | 0.700 |
Why?
|
| Community Health Services | 1 | 2020 | 6 | 0.690 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2020 | 3 | 0.690 |
Why?
|
| Child Welfare | 1 | 2020 | 5 | 0.680 |
Why?
|
| Cyclopropanes | 1 | 2020 | 2 | 0.680 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2020 | 2 | 0.680 |
Why?
|
| Benzoxazines | 1 | 2020 | 2 | 0.680 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2020 | 2 | 0.680 |
Why?
|
| Problem Solving | 1 | 2020 | 14 | 0.680 |
Why?
|
| Pharmacogenetics | 1 | 2020 | 5 | 0.680 |
Why?
|
| Anti-HIV Agents | 1 | 2020 | 5 | 0.680 |
Why?
|
| Genetic Markers | 1 | 2020 | 10 | 0.680 |
Why?
|
| Alkynes | 1 | 2020 | 13 | 0.670 |
Why?
|
| Psychosocial Deprivation | 1 | 2019 | 3 | 0.650 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 77 | 0.650 |
Why?
|
| Depression | 2 | 2018 | 133 | 0.640 |
Why?
|
| Intelligence | 2 | 2019 | 29 | 0.640 |
Why?
|
| Criminal Behavior | 1 | 2019 | 2 | 0.630 |
Why?
|
| Education, Special | 1 | 2019 | 7 | 0.630 |
Why?
|
| Longitudinal Studies | 5 | 2022 | 148 | 0.630 |
Why?
|
| Autistic Disorder | 1 | 2019 | 13 | 0.620 |
Why?
|
| Mutation | 1 | 2020 | 137 | 0.620 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2019 | 2 | 0.620 |
Why?
|
| Schools | 1 | 2019 | 39 | 0.610 |
Why?
|
| Attention | 1 | 2020 | 77 | 0.600 |
Why?
|
| Adaptation, Psychological | 1 | 2019 | 44 | 0.600 |
Why?
|
| Psychometrics | 1 | 2019 | 101 | 0.580 |
Why?
|
| Child Behavior Disorders | 1 | 2018 | 8 | 0.570 |
Why?
|
| Neuroimaging | 3 | 2024 | 25 | 0.570 |
Why?
|
| Maternal Behavior | 1 | 2018 | 11 | 0.570 |
Why?
|
| Orphanages | 3 | 2025 | 7 | 0.550 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 48 | 0.540 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 22 | 0.530 |
Why?
|
| Adoption | 1 | 2015 | 3 | 0.490 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2024 | 14 | 0.440 |
Why?
|
| Pituitary-Adrenal System | 3 | 2024 | 14 | 0.440 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2020 | 20 | 0.430 |
Why?
|
| Child Abuse | 2 | 2025 | 10 | 0.370 |
Why?
|
| Child Language | 2 | 2025 | 18 | 0.350 |
Why?
|
| Cohort Studies | 2 | 2022 | 131 | 0.350 |
Why?
|
| Stroop Test | 2 | 2020 | 4 | 0.340 |
Why?
|
| Connecticut | 2 | 2023 | 4 | 0.340 |
Why?
|
| Vocabulary | 2 | 2020 | 18 | 0.330 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 284 | 0.310 |
Why?
|
| Mental Health | 2 | 2021 | 58 | 0.300 |
Why?
|
| Risk Factors | 3 | 2018 | 184 | 0.270 |
Why?
|
| Genetics, Population | 2 | 2017 | 15 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 250 | 0.270 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 277 | 0.260 |
Why?
|
| Saliva | 2 | 2024 | 20 | 0.260 |
Why?
|
| Auditory Perception | 2 | 2024 | 24 | 0.250 |
Why?
|
| Anxiety | 2 | 2018 | 173 | 0.240 |
Why?
|
| Gene Frequency | 4 | 2018 | 19 | 0.240 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2021 | 9 | 0.230 |
Why?
|
| Metagenomics | 1 | 2024 | 3 | 0.230 |
Why?
|
| Psychopathology | 1 | 2024 | 11 | 0.230 |
Why?
|
| Color | 1 | 2024 | 9 | 0.230 |
Why?
|
| Color Perception | 1 | 2024 | 6 | 0.230 |
Why?
|
| Terminology as Topic | 1 | 2024 | 9 | 0.220 |
Why?
|
| Hydrocortisone | 2 | 2021 | 18 | 0.220 |
Why?
|
| Mammals | 1 | 2024 | 19 | 0.220 |
Why?
|
| Phonetics | 2 | 2021 | 19 | 0.220 |
Why?
|
| Texas | 1 | 2025 | 190 | 0.220 |
Why?
|
| Bacteria | 1 | 2024 | 52 | 0.220 |
Why?
|
| Parietal Lobe | 2 | 2021 | 18 | 0.210 |
Why?
|
| Prospective Studies | 2 | 2021 | 132 | 0.210 |
Why?
|
| Music | 1 | 2024 | 42 | 0.210 |
Why?
|
| Brain Mapping | 2 | 2021 | 78 | 0.210 |
Why?
|
| Risk Assessment | 1 | 2023 | 49 | 0.200 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2022 | 4 | 0.200 |
Why?
|
| Stress, Psychological | 2 | 2021 | 88 | 0.200 |
Why?
|
| Rats | 1 | 2024 | 251 | 0.200 |
Why?
|
| Semantics | 1 | 2023 | 26 | 0.200 |
Why?
|
| Zambia | 1 | 2022 | 2 | 0.190 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 9 | 0.190 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 19 | 0.190 |
Why?
|
| Genomics | 1 | 2022 | 44 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 5 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 2 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 9 | 0.180 |
Why?
|
| Neurites | 1 | 2021 | 7 | 0.180 |
Why?
|
| Cell Count | 1 | 2021 | 33 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 21 | 0.180 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 97 | 0.180 |
Why?
|
| Health Risk Behaviors | 1 | 2020 | 2 | 0.170 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2020 | 6 | 0.170 |
Why?
|
| Public Policy | 1 | 2020 | 4 | 0.170 |
Why?
|
| Mice | 1 | 2024 | 719 | 0.170 |
Why?
|
| Program Evaluation | 1 | 2020 | 28 | 0.170 |
Why?
|
| Educational Status | 1 | 2020 | 30 | 0.170 |
Why?
|
| Disease Progression | 1 | 2020 | 74 | 0.170 |
Why?
|
| Polymorphism, Genetic | 1 | 2020 | 14 | 0.160 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 13 | 0.160 |
Why?
|
| Housing | 1 | 2020 | 11 | 0.160 |
Why?
|
| Socialization | 1 | 2019 | 7 | 0.160 |
Why?
|
| Students | 1 | 2021 | 122 | 0.160 |
Why?
|
| Social Behavior | 1 | 2019 | 26 | 0.160 |
Why?
|
| Crime | 1 | 2019 | 5 | 0.160 |
Why?
|
| Saudi Arabia | 1 | 2019 | 2 | 0.160 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 3 | 0.160 |
Why?
|
| Hippocampus | 2 | 2017 | 73 | 0.160 |
Why?
|
| Linguistics | 1 | 2019 | 10 | 0.160 |
Why?
|
| Prevalence | 1 | 2019 | 72 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 35 | 0.150 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 57 | 0.150 |
Why?
|
| Nerve Net | 1 | 2019 | 46 | 0.150 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 3 | 0.150 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2018 | 5 | 0.150 |
Why?
|
| Maternal-Child Nursing | 1 | 2018 | 2 | 0.140 |
Why?
|
| House Calls | 1 | 2018 | 5 | 0.140 |
Why?
|
| Perinatal Care | 1 | 2018 | 4 | 0.140 |
Why?
|
| Urban Population | 1 | 2018 | 18 | 0.140 |
Why?
|
| Child Behavior | 1 | 2018 | 17 | 0.140 |
Why?
|
| Poverty | 1 | 2018 | 22 | 0.140 |
Why?
|
| Self Report | 1 | 2018 | 72 | 0.140 |
Why?
|
| Siblings | 1 | 2017 | 4 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 350 | 0.140 |
Why?
|
| Animals | 1 | 2024 | 1817 | 0.140 |
Why?
|
| Sex Education | 1 | 2017 | 3 | 0.140 |
Why?
|
| Regression Analysis | 1 | 2017 | 31 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2018 | 52 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 107 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2016 | 16 | 0.130 |
Why?
|
| Age Factors | 1 | 2015 | 75 | 0.120 |
Why?
|
| Middle Aged | 1 | 2018 | 1098 | 0.110 |
Why?
|
| Genotype | 3 | 2020 | 58 | 0.110 |
Why?
|
| Judgment | 1 | 2024 | 12 | 0.060 |
Why?
|
| Acoustic Stimulation | 1 | 2024 | 21 | 0.060 |
Why?
|
| Phenotype | 1 | 2020 | 73 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2018 | 36 | 0.040 |
Why?
|
| Alleles | 1 | 2018 | 20 | 0.040 |
Why?
|
| Comprehension | 1 | 2018 | 33 | 0.040 |
Why?
|
| Nurse-Patient Relations | 1 | 2018 | 2 | 0.040 |
Why?
|
| Canada | 1 | 2018 | 5 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 49 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 5 | 0.040 |
Why?
|
| Pregnancy | 1 | 2018 | 103 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 7 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 9 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 31 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 71 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 8 | 0.030 |
Why?
|
| Memory | 1 | 2016 | 55 | 0.030 |
Why?
|
| Neurons | 1 | 2016 | 131 | 0.030 |
Why?
|